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Background: There are many challenges involved in running randomised controlled dietary intervention trials that
investigate health outcomes. The aim of this paper was to evaluate the recruitment process, retention of
participants and challenges faced in our dairy intervention trial, and to provide strategies to combat the difficulties
of running long-term dietary intervention trials.
Methods: A 12-month, randomised, two-way crossover study was conducted in overweight adults with habitually
low dairy food consumption to assess the effects of a high dairy intake (4 servings of reduced-fat dairy per day)
compared with a low dairy intake (1 serving of reduced-fat dairy per day) on measures of cardiometabolic and
cognitive health. On completion of the high dairy intake phase, each participant was interviewed about their
experience in the trial and responses were used to evaluate the key issues for study participants.
Results: Although the recruitment target was achieved, high rates of attrition (49.3%) and difficulties maintaining
participant compliance (reported by 37.8% of participants) were major threats to the viability of the study. Factors
that contributed to the high attrition included inability to comply with the dietary requirements of the study
protocol (27.0%), health problems or medication changes (24.3%) and time commitment (10.8%).
Conclusion: Attrition and adherence to study requirements present challenges to trials requiring longer-term
dietary change. Including a run-in period to further assess the motivation, commitment and availability of
participants, maintaining regular contact with participants during control phases, minimising time commitment,
providing flexibility with dietary requirements, facilitating positive experiences, and stringent monitoring of diet are
some key recommendations for future dietary intervention trials.
Trial registration: Australia and New Zealand Clinical Trials Registry (ACTRN 12608000538347)
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This 12-month dietary intervention trial was designed to
assess the effects of a high intake of reduced-fat dairy
food on cardiometabolic and cognitive health in over-
weight, habitually low dairy consumers. The difficulties
of running longitudinal studies and randomised con-
trolled trials to investigate health outcomes are well
recognised [1-4]. Implementing a dietary intervention to
assess physical and psychological outcomes of increased
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reproduction in any medium, provided the orincluding recruitment of interested volunteers and main-
taining subject compliance, both critical for the success
of any health research. One of the main challenges pre-
sented by the nature of this investigation is the need to
conduct a long-term evaluation (that is, 6 months) and
the relative benefit of doubling this time in order to con-
duct a crossover that will more than halve the subject
requirement.
The purpose of this article is not to present the results
of the study [5,6], but to indicate some of the difficulties
faced, barriers to completion and challenges of running
longer-term dietary intervention trials. Previous research
examining the challenges of running randomised con-
trolled trials and evaluating health outcomes havel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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period prior to randomisation [1,2], minimising the time
between obtaining consent and participation [4], includ-
ing a lifestyle modification component to the interven-
tion [1], targeting more men during recruitment [1], and
contacting potential participants directly [3]. This study
extends previous research by offering suggestions spe-
cific to dietary intervention trials, based on experiences
in the present trial, to enhance compliance and minimise
attrition. This should assist researchers in their efforts to
successfully implement and assess the effects of similar
studies in the future.Methods
Study design
A 12-month, randomised, two-way crossover dietary
intervention trial was conducted in Adelaide, South
Australia at the Nutritional Physiology Research Centre
(NPRC). The key aims of the study were to assess the
effects of a high intake of reduced-fat dairy food on car-
diometabolic health and cognitive function [5,6]. Over-
weight, habitually low dairy consumers were randomised
to either the high dairy (HD) group (4 servings of
reduced-fat dairy per day) or the low dairy (LD) group
(1 serving of reduced-fat dairy per day). A crossover de-
sign was implemented to allow comparison of the LD
and HD diets within the same individual. Participants
act as their own controls in crossover studies so individ-
ual differences are controlled for, making the error vari-
ance smaller and subsequently reducing the sample size
required to find a significant effect due to increased stat-
istical power [7]. This design was also adopted in an ef-
fort to minimise attrition and to maximise participant
interest and compliance by enabling each participant to
experience both diet conditions and receive complemen-
tary dairy food. Individuals switched to the alternate diet
after 6 months. Ethical approval was obtained from the
University of South Australia Human Ethics Committee.Participants and recruitment
Participants were overweight or obese adults aged 18 to
75 years who had a self-reported habitually low intake of
dairy (<2 servings per day), selected in line with the
average dairy consumption of the Australian population
[8]. Overweight or obese people (body mass index ≥25
kg/m2) were chosen as the target population to assess
the primary outcome measure (waist circumference) and
also because obesity is associated with a greater risk of
cognitive decline [9,10]. Participants also had to be able
and willing to attend the research centre for testing at
baseline and at 6 and 12 months, and be willing to col-
lect dairy weekly for 6 months from the centre while in
the HD arm.Exclusion criteria included being a current smoker,
body weight exceeding 135 kg (maximum capacity of
the dual energy X-ray absorptiometry), diagnosed with
diabetes, cardiovascular disease, liver disease, renal dis-
ease or stage 2 hypertension (>160/100 mm Hg), and
pregnancy or the possibility of pregnancy within 12
months. Consumption of more than 1 g of fish oil per
day, regular use of appetite suppressants, weight loss
medications, or any other medication that may have
influenced the study outcomes prevented inclusion. Par-
ticipants were excluded if they had a known allergy or
intolerance to dairy or lactose, or were considered un-
likely to comply with the study protocol.
Multiple strategies were employed to maximise re-
cruitment. Advertisements seeking people to participate
in a trial examining the health benefits of dairy were
placed in a local newspaper. Similar written advertise-
ments were placed on noticeboards around the univer-
sity and in several public places (local hospital, libraries
and shopping centres). During the recruitment period, a
short interview segment on a current affairs programme
was shown on local television promoting the study and
discussing the possible health benefits of dairy, including
weight loss.
Interested potential volunteers were invited to an in-
formation session and pre-study screening, in which
some simple health measures were taken (height, weight,
blood pressure) and health and dietary questionnaires
were completed to determine eligibility for inclusion in
the study. Potential participants were required to stipu-
late the typical amount, type and brand of milk, yogurt,
cheese, custard, ice-cream, cream and butter they con-
sumed in an average week.
All volunteers understood the dietary and exercise
requirements of the study, and gave informed written
consent if deemed eligible for inclusion. Thirty-six
volunteers were randomised into the HD group, and 35
were randomised into the LD group. All volunteers were
offered monetary compensation of $200 upon comple-
tion of the study for expenses incurred in travelling to
the research centre for testing.
Dairy intervention
Participants randomised to the HD diet were required to
incorporate 4 servings of reduced-fat dairy per day into
their diet. They were required to visit the research centre
weekly (or fortnightly if unable to come in weekly) to
collect 28 servings of dairy provided to them each week.
To ensure the dairy products remained chilled, ice-
bricks and cooler bags were provided to aid with trans-
porting the dairy foods from the research centre. Dairy
products included a selection of reduced-fat milk, yogurt
and custard, and were provided based on personal pre-
ference. All participants were instructed on how to
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their overall energy intake.
During the LD phase, participants were instructed to
continue their usual diet, but to limit their dairy intake
to no more than 1 serving per day. Dairy products were
not provided during this phase of the study as this level
of intake reflected participants’ typical habitual intake.
During the LD phase, participants attended the clinic
only for assessments (at baseline and at the end of each
dietary phase). All participants were instructed to main-
tain their normal physical activity for the duration of the
study.
All participants were provided with verbal and written
instructions on the quantities of different dairy foods
that constitute 1 serving (for example, 250 ml milk, 175
to 200 g yogurt, 190 g custard). Compliance during the
HD phase was measured through the completion of
dairy logs, whereby participants recorded all dairy they
consumed on a daily basis. Weight was measured fort-
nightly; if weight gain was noticed, participants were
offered a time to speak with a registered nutritionist to
discuss ways of incorporating the dairy into their diet.
The aim of the nutritional counselling was to assist the
participant in successfully incorporating the dairy into
their diet by substituting it for other foods. The aim was
not to enforce a particular diet but rather to provide
suggestions allowing the volunteer to make choices on
how to incorporate the dairy.
All participants were sent letters from the research
team in the 2 weeks preceding an assessment to remind
them of their upcoming visit. Any details about specific
requirements (for example, fasting the night before)
were given. Reminder telephone calls were made to each
participant in the week prior to their scheduled appoint-
ment to confirm suitability. If participants did not attend
a scheduled appointment, a maximum of three tele-
phone calls were made and one letter (or email) sent
prior to withdrawing the participant from the study. Par-
ticipants were given every opportunity to either tele-
phone and reschedule, telephone and discuss their
concerns, or withdraw from the study.
Outcome measures
Participants had fasting clinic assessments conducted
over two consecutive mornings at baseline and at 6 and
12 months. The total testing time was approximately 3.5
hours. Water was permitted on the morning of testing
but participants were instructed not to undertake any
physical activity prior to testing. Diet and physical activ-
ity questionnaires (3-day weighed food records, 3-day
physical activity diaries, food frequency questionnaires)
were completed at each assessment.
Blood pressure, anthropometry and biochemistry in-
cluding blood samples were measured at each clinicassessment [5]. Cardiometabolic outcomes included
body weight, waist circumference, percentage total and
abdominal body fat (dual-energy X-ray absorptiometry),
systolic and diastolic blood pressure, fasting plasma glu-
cose, triglycerides, high-density lipoprotein, low-density
lipoprotein and total cholesterol, resting metabolic rate
(by indirect calorimetry), and arterial compliance (pulse
wave velocity). The cognitive assessment consisted of a
battery of 10 neuropsychological tests, a depression,
anxiety and stress questionnaire, and one measure of
pre-morbid intelligence [6]. A wide range of cognitive
abilities were assessed, including information-processing
speed, attention, memory, verbal functions and language,
concept formation and reasoning, executive function,
and perception. The cognitive testing component took
approximately 1 to 1.5 hours to complete.Participant feedback
The high number of participants who dropped out of
the study (outlined in Figure 1) made it apparent that
participants were finding the trial challenging and that
study completion with adequate power would be in
doubt. Consequently, in order to gain constructive and
honest participant feedback about the trial, a 15-item,
face-to-face open-ended interview (Appendix A) was
added to the study and conducted with each participant
who completed 6 months on the HD diet at the end of
this phase. The questions were based around the follow-
ing broader topics: dairy and food, dietary habits, sup-
port/learning, and practical considerations of study
involvement. Examples of questions asked included ‘did
you learn anything about your dietary patterns or eating
habits while on the high dairy diet?’ and ‘what was the
most difficult thing about being in the trial?’ Interviews
were conducted with only 37 participants (11 males and
26 females) and took between 10 and 20 minutes to
complete. Thirty-six of the 37 participants completed
the 12-month trial.Data analysis
Based on waist circumference, the primary outcome
measure, a total sample of 34 participants was estimated
to give 80% power to detect an effect size of 0.5
(predicted change/standard deviation of change) at an α
value of 0.05 [11]. Statistical analyses were per-
formed with SPSS for Windows, version 18.0 (SPSS Inc.,
Chicago, IL, USA). Analysis of variance and chi-square
tests were used to determine any differences in baseline
demographic, cardiometabolic or dietary variables be-
tween those who completed the entire 12 months of the
study (completers, n= 36), those who completed part of
the study but withdrew prior to completion (late drop-
outs, n= 25), and those who were screened and enrolled
84 responses to recruitment strategies & screened
71 screened & deemed eligible
13 screened & excluded:
Dairy intake too high: 9
Dairy intolerance: 2
Thyroxine medication use: 2
5 withdrawals
No contact made: 3
Change in medications: 1
No reason given: 1
36 randomly 
allocated to HD 5 withdrawals
Time commitment: 2
Change in medications: 1
Change to diet/exercise: 1
No contact made: 1
2 withdrawals
Unwilling to eat 4 serves dairy/d: 1
Moved away from study location: 1
6 withdrawals
Personal reasons: 3
Change to diet/exercise: 1
Unwilling to eat 4 serves dairy/d: 1
Medical condition: 1
23 completed
12 month
assessment
13 completed 
12 month 
assessment
11 withdrawals
Medical condition: 3
Change to diet/exercise: 3
Time commitment: 2
No contact made: 2
Change in medications: 1
1 withdrawal
No contact made: 1
Cross-over 
at 6 months
24 to LD
LD to HD: 4 withdrawals at 
cross-over
Not willing to cross-over to HD: 3
Medical condition: 1
HD to LD: 1 withdrawal at 
cross-over
Medical condition: 1
35 randomly 
allocated to LD
31 completed 
baseline
assessment
30 completed 
baseline
assessment
25 completed 
6 month 
assessment
19 completed 
6 month 
assessment
Cross-over 
at 6 months
15 to HD
Figure 1 Participant flow and attrition. Study design, randomisation to the high dairy (HD) and low dairy (LD) diets, and participant flow
through the study, including reasons for withdrawal at all stages.
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(early drop-outs, n= 10).
Results
Recruitment and retention
Eighty-four potential participants expressed an interest
in participating and were screened. The most interest
for participation was generated from a segment shown
on television about the health benefits of dairy (35.7%
of respondents), from an advertisement in the local
newspaper (31%), and from participants who had pre-
viously participated in studies at the research centre
and had indicated an interest in being contacted for
future studies (16.7%). Of the 84 people who wereinitially screened, 71 were eligible to participate, gave
consent and were enrolled and allocated to treatment.
Sixty-one participants (18 male, 43 female), completed
a baseline assessment. A further 25 participants with-
drew from the study after completing a baseline as-
sessment. A significantly larger number of participants
who were initially randomised to the LD diet, com-
pared with the HD diet, withdrew from the study (22
compared with 13; P <0.05). In total, 36 adults (10
males, and 26 females) aged 18 to 71 years completed
the 12-month study. The overall drop-out rate was
49.3%. Figure 1 outlines the number of participants
recruited and tested at each time point, and the rea-
sons for withdrawal.
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were an inability to adhere to the dietary or physical ac-
tivity requirements of the study (27.0%), changes the
participant intended to make that would interfere with
study outcomes, such as starting new medication or hav-
ing a medical condition revealed during the course of
the study (24.3%), and time commitment (10.8%).
Although there were more females (n=51) than males
(n= 20) in the study, there was not a significant difference
in drop-outs in terms of gender (Table 1). Completers had
significantly lower percentage abdominal fat at baseline
than drop-outs (P <0.05). There were no other significant
differences between completers and noncompleters.Table 1 Demographic, cardiometabolic and dietary characteri
Demographic variable Early drop-outsa (n=10) D
Initial diet allocation
High dairy 5 (7.0)
Low dairy 5 (7.0)
Gender
Male 2 (10.0)
Female 8 (15.7)
Presence of medical conditions 3 (30)
Taking medications 6 (60)
Alcohol consumption (>2×/week) 1 (10)
Physical activity (≥3×/week) 8 (80)
Age (years) 44 (12)
Weight (kg) 95 (15)
Waist circumference (cm) NA
Body mass index (kg/m2) 36 (6)
Total body fat (%) NA
Abdominal fat (%) NA
Systolic BP (mmHg) 125 (11)
Diastolic BP (mmHg) 75 (8)
Total psychological well-being (DASS)d NA
Depression NA
Anxiety NA
Stress NA
Energy intake (MJ/day) NA
Protein (g/day) NA
Fat (g/day) NA
Carbohydrate (g/day) NA
Alcohol (g/day) NA
Calcium (mg/day) NA
Demographic, cardiometabolic and dietary characteristics of the total sample (n= 7
intervention (early drop-outs) with those who withdrew during the study and with
(standard deviation). BP, blood pressure; NA, not assessed; NS, not significant. aPart
variance for continuous variables; chi-square test for categorical variables. cAll drop
dDepression Anxiety Stress Scale (DASS) assessed only in the cognitive subgroup (d
anxiety/stress.There was no evidence of any period, order or sea-
sonal effects for any of the cardiometabolic or cognitive
outcomes [5,6]. Total energy intake and physical activity
at the end of the two diet phases did not differ according
to the order of intervention. Compliance during the HD
phase was excellent; the average weekly intake of dairy
was 25.2 ± 3.1 servings of the provided dairy and
2.9 ± 2.4 servings of the participant’s own dairy, giving a
total intake of 28.1 ± 2.6 servings for those who com-
pleted the HD phase. Adherence to completing the diet
and physical activity questionnaires was also very good,
with 89% of participants completing all questionnaires at
each time point.stics of the total sample at baseline
rop-outs during study (n=25) Completers (n=36) P valueb
8 (11.3) 23 (32.4) 0.013c
17 (23.9) 13 (18.3) 0.013c
8 (40.0) 10 (50.0) NS
17 (33.3) 26 (51.0) NS
7 (28) 13 (36) NS
9 (36) 13 (36) NS
5 (20) 8 (22) NS
20 (80) 32 (89) NS
45 (16) 49 (14) NS
93 (19) 89 (17) NS
101 (14) 98 (14) NS
33 (5) 32 (6) NS
45 (7) 43 (9) NS
47 (6) 43 (7) 0.043
132 (1) 127 (14) NS
78 (11) 74 (11) NS
18 (17) 14 (19) NS
5.3 (7.9) 3.9 (6.2) NS
3.8 (4.0) 3.2 (5.9) NS
9.3 (8.3) 7.1 (7.8) NS
8.8 (2.3) 8.9 (3.2) NS
95 (26) 96 (32) NS
82 (30) 80 (39) NS
219 (66) 231 (90) NS
8.5 (11.1) 7.6 (12.4) NS
920 (352) 1096 (764) NS
1) at baseline, comparing those who withdrew before commencement of the
those who completed the 12-month study. Data presented as n (%) or mean
icipants withdrew between screening and baseline assessment. bAnalysis of
-outs grouped together (n= 35) and compared with completers (n= 36).
rop-outs, n= 21; completers, n= 31); higher scores indicate greater depression/
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Gaining information about aspects of the study that par-
ticipants found most challenging was an important com-
ponent of the interview, and was the primary reason for
adding these interviews to the study (Table 2). The most
frequently reported reasons for finding the study difficult
were the regular visits to the research centre for dairy
collections and consuming the required dairy food. The
interviews did reveal some positive or beneficial aspects
of participation. These included eating the dairy, meet-
ing new people, and having health assessments.
The HD diet had a positive impact on other eating
habits for some people. Many participants made some
healthy changes to their diet to incorporate the dairy, such
as eliminating foods high in fat or sugar and replacing
them with the reduced-fat dairy. One may speculate that
as a result of making dietary changes and diet monitoring
by completing dairy logs and 3-monthly food records, par-
ticipants became more aware of any pre-existingTable 2 Reflection interview responses: positive and
negative aspects of study participation reported by
participants
Aspect of study Total number
of responsesa
Positive
Eating dairy 17
Meeting new people (researchers) 9
Health assessment/observing any changes in health 7
Trying something new in diet 5
Visits to the centre 4
Feel like helping 2
More aware of physical activity 2
Becoming more aware of own diet 1
Cognitive testing (interesting/enjoyable) 1
Weight loss 1
Budget (free dairy food) 1
Negative
Coming to centre for dairy collections/traffic/parking 17
Eating the dairy 9
Monitoring/adjusting diet/having to plan meals 5
Reducing dairy intake in low dairy condition 5
Time off work/time commitment 4
Blood-taking 2
Fasting 2
Weight gain 1
Weighing food 1
Positive and negative aspects of study participation as reported by
participants at the completion of the high dairy dietary phase (n= 37).
aQuestions were open-ended, allowing for multiple responses from each
individual.unhealthy eating habits. Of the 37 participants who com-
pleted the HD intervention and interview, 27 reported
that at the end of the study they would be more likely to
consume more dairy than they did prior to the study.
Discussion
Two of the major challenges to any long-term study are
the recruitment and retention of eligible study members
for the duration of the study. While recruitment targets
were met in the present study, retention was poor. Attri-
tion is problematic as it can result in a study being statisti-
cally underpowered and can threaten external validity if it
results in a more homogeneous sample than the original
representative group. Attrition as a result of the interven-
tion being studied may selectively bias the results having a
detrimental effect on the internal validity of the study.
The treatment effect can also be influenced as attrition
may result in non-random missing data because those that
withdraw do not receive the full intervention. While attri-
tion in this crossover trial was high, it did not affect power
because 34 participants were required. In addition to these
direct problems, attrition also results in an inefficient ex-
penditure of time and resources. The aim of all research
involving human participants is to minimise all types of
attrition in order to maintain maximum statistical power,
and to minimise selection bias.
Attrition is well recognised as a common problem in
health research and weight-loss studies. Socioeconomic,
demographic, behavioural and health factors among par-
ticipants that may predict participation or drop-out have
been extensively examined. Medical conditions accom-
panying overweight or obesity in participants and simul-
taneous treatment may influence both attrition and
outcome [12]. The attitudes to healthy eating and dieting
in an overweight group may also be relevant factors
when considering study retention, because attrition in
obesity studies has been positively [13] and negatively
[14] associated with binge eating, and positively and
negatively associated with previous dieting [15]. Practical
difficulties have been attributed as explanations for attri-
tion in randomised controlled trials, including family or
work problems, logistic difficulties such as travel and
associated costs, and having to attend additional
appointments [16-18]. Drop-out due to a perception that
the intervention will not be of benefit, because early suc-
cess is not seen, or because the participant is not rando-
mised to their desired intervention are recognised
threats to health research [16-19]. Depression [4,19,20]
and low self-esteem [2] are frequently cited predictors of
attrition. The findings of Fabricatore and colleagues sug-
gest that higher baseline depression, even below levels of
clinical severity, may also negatively impact upon the
individual’s ability to make behavioural changes involved
in weight loss [2].
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Recruitment, retention and challenges
The high attrition rate was not anticipated in the present
study, particularly from within the LD group. The rea-
sons for attrition were consistent with past research. Lo-
gistic difficulties, the health characteristics of the study
population, and having unrealistic study expectations
and treatment preferences were all factors that contribu-
ted to the high drop-out rate. Surprisingly, logistic diffi-
culties appeared to be the main reason for drop-out
from within the LD group, whose time commitment was
considerably less than for those in the HD group. One
may suspect that the anticipated upcoming time com-
mitment during the next (HD) phase was the reason for
their withdrawal.
Those participants who withdrew between screening
and the final assessment were slightly younger than
those who completed the study. Perhaps older indivi-
duals such as retirees may have been more compliant
and willing to participate as they had more time, and
enjoyed the process of coming into the research centre
and having social contact with the study team. One
could also hypothesise that older individuals feel more
responsibility to complete something that they have
commenced, or are more motivated to make a behav-
ioural or lifestyle change to improve their health if they
have experienced some degree of impairment already
[2]. While considerably more women than men were en-
rolled in the present study, which may reflect a greater
interest in health and/or diet by women, attrition was
not significantly different between genders.
Adherence to the study protocol was a major chal-
lenge. One may speculate that overweight or obese
people may find it particularly difficult to make a long-
term dietary change, particularly in the absence of any
immediate results. A lack of early success while on the
HD diet, in terms of weight loss, probably contributed
to the withdrawal of four participants. These volunteers
put on between 0.4 and 2.3 kg in the first 6 weeks of the
HD intervention. For 6 months, participants were
required to make some considerable changes to their
eating habits. In addition to increasing their intake of
dairy, they had to ensure that their overall energy intake
was not increased by incorporating the dairy rather than
simply adding it to their normal diet. Participants were
therefore required to not eat other foods or beverages to
prevent weight gain. Although the dairy food was pro-
vided free of charge, the ability to consistently consume
4 servings per day and forgo certain other foods may
have been too challenging. Reasons that emerged from
the reflection interviews as to why this dietary change
was difficult included the quantity of dairy that had to
be consumed, the daily consumption becoming repeti-
tive and boring, and a lack of choice of dairy foods.The long duration of the trial certainly impacted on at-
trition, as participants found it difficult to maintain the
increased dairy intake for 6 months. Some participants
reported that planning their meals and selecting new
recipes to incorporate the dairy were added burdens.
Consequently, the inability to incorporate the dairy
whilst still eating other food may have resulted in weight
gain, frustration and subsequent drop-out.
Dietary intervention studies may be particularly chal-
lenging for depressed individuals if they eat to combat
their negative feelings or other symptoms of depression.
As a result they may be unable to comply with the study
requirements if a strict diet is required. Depression may
not only predict drop-out, but may also impact upon
outcomes. The present study did not support this re-
search. Baseline psychological well-being (depression,
anxiety and stress) was assessed in the participants en-
rolled in the cognitive component of the study (n= 52 at
baseline). Depression, anxiety and stress scores (and
total composite score) did not differ significantly be-
tween those who completed the study from this sub-
group (n= 31) and those who withdrew (n= 21).
Depression scores did not significantly differ between
dairy diet phases, indicating that dairy consumption did
not impact depression.Study limitations
Total energy intake was increased during the HD period,
indicating poor compliance with the instruction to sub-
stitute dairy for other foods. Expecting participants to
achieve this in the present study without an individua-
lised dietary plan is an acknowledged limitation.
The reflective interview was conducted with 37 parti-
cipants, but only 36 of these completed the study. The
views of those who stayed in the study versus the partici-
pant who withdrew are unable to be separated, and this
information may have provided additional insights into
how attrition could be minimised in future trials. Simi-
larly, other factors that may affect attrition were not
examined in the present study, such as attitudes toward
food, dieting and weight loss, or motivation to change.
Whether these factors may have impacted upon attrition
in the present study cannot be determined.
Compliance may also have been better if a greater var-
iety of dairy foods, as in real life, was included. Milk and
yogurt were the predominant dairy foods supplied in the
present study; dairy foods such as ice-cream and cheese
(for example, cream cheese, cottage cheese) were not
included. These dairy products were chosen because of
their high whey protein content, as whey (rather than
casein protein) is thought to play a role in the anti-
obesity effect of dairy [21]. For example, a cheese slice
on a sandwich is an easy way to incorporate dairy, but
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Recommendations for future trials
Successful recruitment and screening
Recruitment should involve a variety of methods to at-
tract a wide range of volunteers, of desired type and
number, and thereby increase representativeness. A thor-
ough pre-study screening session to determine the eligi-
bility of each potential volunteer is essential, strict
inclusion and exclusion criteria must be adhered to, and
the study protocol and requirements should be thor-
oughly explained. The screening procedure should be
completed in a timely manner, and the time between
when consent is given and the study commences should
be minimised [4]. Engaging interest early may help to
prevent very early drop-outs before the study interven-
tion begins. Further recruitment may be considered if
the number of early drop-outs is high, but consideration
must be given to cost and the additional time that this
will add to the study.
Including a run-in period – a time after enrolment but
before randomisation that allows further assessment of a
participant’s eligibility and commitment to a study –
may be worthy of consideration. Incorporating this time
into a study enables the individual to think further about
what their participation will require, and, secondly,
allows the researcher to more thoroughly estimate par-
ticipant compliance. Low motivation, poor commitment
or limited availability may exclude a potential participant
before the study commences.
Flexibility with a nutritional intervention
Offering a range of different products and brands that
still meet the nutritional requirements of the study
would be recommended for future dietary trials. The
provision of an additional dairy option (reduced-fat cot-
tage cheese) was made available to some participants
who were finding it difficult to consume 4 servings from
milk, yogurt and custard. Providing the participants with
a selection of different dairy products was a way of giv-
ing them some control in this intervention study, and
would be recommended in the future.
Reducing time commitment
Minimising the time commitment during any long-term
trial is important. Providing alternative dairy collection
points may have helped reduce this burden by providing
a more convenient location to pick up the dairy, such as
at grocery stores.
Maintaining regular contact
Contact with participants during a control phase
when they are otherwise not actively involved in anyintervention is needed. In a dietary study, control food
products could be provided as a means of maintaining
both contact and participant interest. This may include a
selection of healthy food products such as fruit and vege-
tables. The additional contact may maintain the partici-
pants’ awareness and interest in both the study and their
dietary patterns, and may have the added benefit of taking
the focus away from the main study food so that the parti-
cipants do not focus on one arm more than the other.
Monitoring of compliance and nutritional counselling
The provision of more stringent instructions on what
participants are allowed to consume during an interven-
tion phase and stricter monitoring of overall energy in-
take would be recommended for future trials. This could
be achieved through the provision of an independent
dietary plan to each participant with specific details
regarding the quantity of other foods and beverages that
would need to be removed from the diet in order to
maintain isocaloric intake. The use of empathic staff (for
example, nutritionists) to implement sound, structured
dietary guidelines should be utilised. Adding a third arm
to the study with the aim of weight loss (increased dairy
food intake in combination with energy deficiency) may
have been of benefit in terms of achieving the study aims
and generating and maintaining interest in the trial.
Follow-up after nonattendance
Every endeavour should be made to contact any partici-
pant who does not attend an appointment, in the hope
of rescheduling visit times or providing an opportunity
for the individual to discuss why they may not want to
attend.
Facilitate positive aspects of trial participation
Factors that play a positive role in the experiences of
participants should be facilitated for all participants.
Positive experiences such as meeting new people, visiting
the research centre and trying something new in the diet
should be highlighted and encouraged.
Financial rewards
Financial compensation has been demonstrated to maxi-
mise compliance [22]. Higher financial rewards may be
required when a significant dietary change is required
for a long duration.
Conclusions
Improving our understanding of the risk factors for attri-
tion either via active withdrawal or nonreturn may help
to plan studies in the future to minimise attrition. This
includes the identification of motivations to participate
and barriers that inhibit completion. All potential parti-
cipants need to have a clear understanding of what the
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and what they may realistically expect in terms of results
throughout the study period in order for them to com-
mit to the study. A run-in period may help to achieve
this. Minimising the time commitment and burden
required of participants at all stages is important, as is
maintaining regular telephone contact with participants
who are not required to attend regular appointments.
This could alternatively be achieved through the
provision of a control diet or food to increase involve-
ment during the control phase. Detailed, clear and indi-
vidualised dietary guidelines need to be provided to
participants who are required to make a substantial
change to their diet. Positive experiences of trial partici-
pation should be facilitated. Including a measure of
health beliefs, attitudes toward eating and dieting history
may also help to inform the characteristics of an over-
weight population.
Identifying and addressing any barriers to participation
is an important step in minimising the problems asso-
ciated with high attrition. The challenges faced and les-
sons learned from this study are applicable to any
intervention trial in which subjects are required to make
a long-term dietary change. Reducing the incidence of
attrition in any long-term intervention or longitudinal
research will maximise both internal and external valid-
ity and will enhance the overall quality of data collected.
Appendix A. Reflection interview
A.1. Dairy and food behaviours
1. How did you find increasing your dairy intake?
2. Was incorporating 4 serves of dairy each day easier
or harder than you thought it might be?
Why?
3. Did you find that you tended to incorporate the
dairy into your diet at a specific time of day?
When? (e.g., morning/middle of day/evening)
4. What dairy food did you like
a) the most?
b) the least?
5. Did being on the high dairy diet influence:
a) your food or beverage choices at home?
b) how you planned your other meals?
c) your normal cooking habits?
d) food or beverage choices if you went out to eat/
drink?
e) other members of your family?
6. Do you think differently about dairy now compared
to 6 months ago?7. How do you feel now about reducing your dairy
intake to less than 1 serve per day?
8. At the end of 12 months are you likely to eat more/
less/or similar amounts of dairy than you did prior
to your participation in this trial?
A.2. Support/learning
9. Have you learnt anything about yourself being in
this study to date?
10. Did you learn anything about your dietary
patterns/eating habits while on the high dairy diet?
11. Did you feel like you had adequate support:a) from the staff here? (If not, what more could we
have done to help your experience?)
b) from your family or friends?Appendix B. Practical implications
12. What have you enjoyed the most about
participating in this trial?
13. What was the most difficult thing about being in
the trial?
14. Did it get any easier or harder as the time went on?
15. Would you be happy to participate in any future
studies at the NPRC?
16. Is there anything else you would like to tell me
about your experience?
Abbreviations
HD: high dairy; LD: low dairy.
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